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2ABSTRACT
The applicability of a stochastic model was explored to assess the impact of a new
independent agency for animal health in England in terms of the cost of animal disease
outbreaks. The new agency was proposed to take responsibility for animal disease management
in England. The stochastic model estimates the likelihood that the proposed new agency would
face animal disease outbreaks of major and minor magnitude; and how many outbreaks of each
magnitude, within its first 30 years of operation. Large variability in the potential total cost of the
new agency was attributable to the possibility of an outbreak of an unknown major disease,
although Bluetongue, Foot and Mouth Disease, and Avian Influenza were also influential. The
results show that if the new agency reduces disease costs by even 0.5%, this could benefit society
by an estimated £21 million per year. The stochastic approach offers a method for dealing with
uncertainties in any continuing deliberations regarding the proposed new agency, resulting in a
potential annual gain of £73 million ranging to an annual loss of £144 million.
Key Words: animal disease; risk assessment; environmental policy; impact assessment,
stochastic approaches.
3INTRODUCTION
Outbreaks of animal diseases have enormous economic, social, and environmental
consequences to the UK national economy (Anderson 2002, 2008). Mitigating these requires a
comprehensive and informed risk management scheme. Currently in the UK, the responsibility
for animal disease management lies with the Department for Environment, Food and Rural
Affairs (Defra). This responsibility was proposed to transfer to a new independent agency for
animal health in England by 2012, although Defra ministers would retain overall responsibility
for animal disease policy (Defra 2009a). The proposed new agency (herein, ‘the new agency’)
was part of the Government’s drive to achieve efficiency in animal disease management in
England. To assess the investment potential of the new agency, Defra (2009b) relied on expert
opinion about disease risks based on the return periods (RP) of Avian Influenza, Bluetongue,
Newcastle Disease, Classical Swine Fever, Foot and Mouth Disease, African Swine Fever, and
Swine Vesicular Disease. The RP is the mean length of time between outbreaks that have
equalled or exceeded a certain magnitude. The reciprocal of the RP is a probability estimate of
the event occurring in any given year (Ozger and Sen 2008).
Return periods are widely used to reflect the magnitude of flood events, but a limitation
of using the RP of diseases to assess the risk of future animal disease outbreaks is that the RP
does not account for variations in the distribution of what are often rare outbreaks involving
highly complex chains of precursor events (Gosling et al. 2011). For example, as the new agency
has been proposed to exist for 30 years (Defra 2009b), a disease with an RP of 60 years may or
may not occur during the lifespan of the new agency. This can affect the rationale for the new
agency. Here, we use a stochastic model to build on the RP of the diseases (Defra 2009b) in
order to assess the impact of the new agency. The stochastic model was developed to estimate
the likelihood that the new agency would face disease outbreaks of both major and minor
magnitude; and more importantly, how many outbreaks of each magnitude, within its first 30
years of operation. It uses the estimated costs of disease outbreaks and the running costs of the
new agency to present the possible benefits of the new agency under four hypothetical scenarios.
METHODS
A stochastic model was developed to estimate the number of animal disease outbreaks
that may occur within the 30-year lifespan of the new agency. Adopting a stochastic approach
4allowed the incorporation of variability (Ranjan and Lubowski 2005), and provided additional
information to the expected number of outbreaks, e.g., 5th and 95th percentiles.
To make decisions covering the lifespan (30 years) of the new agency, the number of
minor and major outbreaks of animal disease were estimated. The distinction between major and
minor outbreaks is a simplistic representation of disease outbreaks that encompasses the average
costs for minor disease outbreaks controlled at low cost, and much rarer years of one (or even
more) major high cost disease outbreak(s). These range from small (one animal or premises
affected, with minimal trade disruption) to nationwide (thousands of affected premises, very high
eradication costs, and long disruption to businesses) (Defra 2009b). This enabled an estimation
of the total cost of outbreaks to which set-up and running costs of the new agency could be
added. Data available from Defra (2009b) provided information on the likely frequency (i.e., an
outbreak once every “how many” years) of an exotic disease outbreak for different diseases
(Table 1). Using these data, the analysis focused on nine diseases, i.e., Avian Influenza (AI),
Bluetongue (BT), Newcastle Disease (ND), Classical Swine Fever (CSF), Foot and Mouth
Disease (FMD), African Swine Fever (ASF), and Swine Vesicular Disease (SVD). It is important
to emphasise that the probabilities and costs provided by Defra reflect expert opinion about
disease risks based on the information available. The data used by the Government’s expert
elicitation panel dates back to year 1866 (Defra 2009b). The figures are not intended to be
forecasts nor predictions of what will happen; rather to illustrate the possible scale of outbreak
costs in a year to show what might be achieved by reducing those costs.
The stochastic model was developed using the @Risk™ (v5.5, Palisade Corporation)
add-on to Microsoft Excel (Charles and Ashbolt 2004). To estimate the number of outbreaks of
disease i (i = 1,…, 9) within a 30-year period (Oi) a Poisson distribution was used (Vose 2008),
which assumes that each outbreak is independent of each other (IRMA 2003; Williams et al.
2009; Willeberg et al 2011). This is given as
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where yi is the estimated number of years between outbreaks of disease i, which is given from
Table 1.
The cost of the disease outbreak is dependent on whether the outbreak is major or minor.
The probability of a minor outbreak of disease i (Pi,Minor) and the probability of a major outbreak
5of disease i (Pi,Major) were also taken from Defra (2009b) and are detailed in Table 1. Using the
probability Pi,Minor, the number of minor outbreaks (Oi,Minor) was determined by a Binomial
distribution:
Oi, Minor = RiskBinomial(Oi, Pi, Minor)
and therefore, the number of major outbreaks (Oi,Major) was given by subtracting the number of
minor outbreaks from the total number of outbreaks, i.e., Oi,Major = Oi - Oi,Minor.
The cost Ci of outbreaks of animal disease i in the 30-year period was therefore
calculated as:
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where ci,Minor is the incident cost in millions (£M) if outbreak of disease i is minor and ci,Major is
the incident cost (£M) if outbreak of disease i is major.
The yi and ci,major of “unknown major disease” were determined by Defra (2009b) based
on their historical data of outbreaks that are, for example, similar in scale to the BSE outbreak in
the UK during the 1980s/early 1990s, and have been in the past highly unlikely event (1% risk in
any year) but if it should arise it would cause very high costs (e.g., £5 billion – similar in scale to
BSE). The very high cost of such an event leads to the high “expected annual cost”.
For the purpose of undertaking a cost-benefit analysis of the proposed new agency, the
estimated set-up and annual running cost of the new agency were taken from Defra (2009b), i.e.,
£14.3 million and £2.7 million, respectively. Therefore, the total cost, C, (£M) of set-up and
running the new animal health agency and of outbreaks in the 30-year period under consideration
was determined in this paper as:
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These data were used in the following four scenarios (A-D) to estimate the total financial
benefit of the new agency. The percentage cost reductions were arbitrarily determined and
initially set out by Defra (2009b).
 Scenario A: Design and establishment of the new agency would result in 0.5% (non-
compounding) reduction outbreak cost over a 30-year period.
 Scenario B: Design and establishment of the new agency would result in 2% (non-
compounding) reduction in outbreak cost over a 30-year period.
6 Scenario C: Design and establishment of the new agency would result in 10% (non-
compounding) reduction in outbreak cost over a 30-year period.
 Scenario D: Design and establishment of the new agency would result in 0.5%, 2% and 10%
(non-compounding) reduction in outbreak cost each year for years 1–10, 11–20, and 21–30,
respectively.
For Scenarios A–C in the scenario analysis, the costs of each outbreak were reduced
accordingly. Within Scenario D, the number of (major and minor) outbreaks within each 10-year
period was estimated and outbreak costs (with associated reductions 0.5%, 2%, 10%) applied to
each period. The costs of outbreaks in the 30-year period were subsequently calculated by adding
together the costs from the three periods considered, in addition to the set-up and running costs.
In addition to the above scenario analysis, the impact of the new agency having an
increased probability of an outbreak being minor (Pi, minor) was investigated for each disease on
the total cost of the disease outbreaks (under the baseline scenario, i.e., without any additional
financial benefits).
The Monte Carlo simulation model was executed using @Risk™, with latin hypercube
sampling, and run for 100,000 iterations. This number of iterations was sufficient to ensure
convergence for the means of the number of minor and major outbreaks within a 95% confidence
level (3% tolerance), which are the default settings in @Risk™. Sensitivity analyses were
undertaken using @Risk™ (Vose 2008) in order to ascertain the relative importance of all
variables to the cost of animal disease outbreak for the baseline model.
RESULTS
Based on the simulated probabilities of a minor outbreak of disease i (Pi,Minor), the
estimated number of minor outbreaks (Oi,Minor) over a 30-year period is shown in Figure 1. This
shows, for example, the number of minor outbreaks of ND was estimated to have a mean value
of 9.5 (5th percentile 5; 95th percentile 15). Likewise, provided in Figure 2 is an estimate for the
number of major outbreaks (Oi,Major) over 30 years based on the simulated probabilities of a
major outbreak of disease i (Pi,Major). From Figure 1, AI has a substantially higher number of
minor outbreaks in a 30-year period (54 (42, 66)) compared to the other animal diseases. The
90th percentile range (2, 10) for major outbreaks of AI overlaps with other diseases, e.g., BT,
7CSF, OKN (Figure 2). Therefore the number of major AI outbreaks is more similar to the other
animal diseases considered.
The estimated costs (£M) due to minor and major animal disease outbreaks in 30 years
(Ci) are shown in Figure 3. Although it is predicted that the largest number of outbreaks will be
from AI, it is the costs associated with an outbreak of an UMD that are the highest. In addition,
the variability about the cost is wide with the 95th percentile at £5000 million. This is because,
although the probability of having such an outbreak is low (1 in every 100 years), the cost of
such an outbreak was estimated to the £5000 million. BT outbreaks would also be costly to the
new organisation, but the situation is slightly different here because the probability of an
outbreak is high (once in every 2 years) and the cost is also relatively high. The costs of an AI
outbreak are relatively low, and therefore although a high number of outbreaks may occur,
overall, this disease would not contribute most to the cost of managing disease outbreaks. The
other diseases have a much lesser impact on the estimated mean cost of outbreak management
over a 30-year period.
Based on the total mean cost per outbreak of the diseases and the likelihood that the
disease outbreaks will occur over the 30-year period, total disease outbreaks (i.e., across all
diseases) could potentially cost £4118 million (1925, 8440). The large degree of variability
associated with this overall estimate (as seen from the 5th and 95th percentiles) is attributable to
the variability associated with an outbreak of an UMD, as discussed above.
From the scenario analysis (A-D) the costs of outbreak based on the estimated savings
from setting up the new agency are compared in Figure 4. This shows, for example, if the new
agency achieved a reduction of 2% in the cost of animal disease outbreaks over 30 years
(Scenario B), and with the expected cost of disease outbreaks over this time totalling £4118
million (1925, 8440) and the estimated set-up and annual running cost of the new agency (£14.3
million and £2.7 million, respectively), this would benefit £80 million. Likewise, if the new
agency achieved a reduction of 0.5%, 2%, and 10% in the cost of animal disease outbreaks each
year for years 1–10, 11–20, and 21–30, respectively (Scenario D), this would benefit £167
million after the set-up and annual running costs of the new agency are accounted for. Even at
the minimal benefit of the new agency achieving a reduction of 0.5% in the cost of animal
disease outbreak over 30 years (Scenario A), and with the set-up and annual running costs of the
new agency, this would benefit £21 million.
8An additional scenario analysis was carried out for the probability of an outbreak of
disease i being minor (Pi,Minor) to see the effect of an improved outbreak response initiative on
the mean expected total cost of disease outbreaks without financial benefits from setting up the
new agency (Figure 5). For all of the diseases, except for UMD (for which by definition Pi,Minor =
0), Pi,Minor was increased from its baseline value given in Table 1. From this analysis it is
predicted that an improved outbreak response for AI and BT, in particular, could greatly reduce
the costs of animal disease outbreak. The model is more sensitive to these two diseases because
they are predicted to occur most frequently (i.e., two AI outbreaks per year and one BT outbreak
every 2 years).
A tornado chart for the sensitivity analysis is shown in Figure 6. This shows that the total
estimated cost of animal disease outbreaks over the 30 years was highly sensitive to the potential
for an outbreak of a UMD. The other influential diseases were BT, FMD, and AI.
DISCUSSION
The use of a stochastic model enhances the RP method for dealing with the uncertainties
regarding the proposed new agency for animal health in England. The RP approach assumes
constant risk levels and factors over a decision period. When presenting the potential cost of
future exotic disease outbreaks, Defra (2009b) acknowledge that the figures are not forecasts or
predictions of what will, or is likely to, happen. Rather they illustrate the possible scale of
outbreak costs and illustrate what might be achieved by reducing those costs. Animal disease
spread changes in nature. Unknown animal diseases may emerge (e.g., Bovine Spongiform
Encephalopathy), or new disease may appear through intrusion (e.g., African Horse Sickness) or
environmental change (e.g., Bluetongue). While the stochastic model developed here
incorporated RP, it also enabled observation of the probability of one or more outbreaks
occurring within a specified time period. The stochastic approach therefore has a higher
resolution than RP alone for assessing the impact of the new agency (Barbolini et al. 2003).
Compared to any deterministic approach, it provides additional information on the possible
number of outbreaks and costs by providing 5th and 95th percentiles (Galson Sciences Limited
2001). However, it is important to note the inherent assumptions within this stochastic model.
For example, over a 30-year period, the predicted frequency of the different outbreaks is likely to
change dependent on the worldwide animal disease situation. Such changes would be potentially
9significant and it is therefore important that these data for the “chance of outbreak” are reviewed
on a regular basis to assess if still realistic. Likewise the probability of a minor or major outbreak
may change over time, dependent on outbreak control measures and livestock industry structures
(e.g., animal movements). However, the scenario analysis carried out for Pi,Minor indicates the
total cost of the agency would only be significantly affected by changes in Pi,Minor for AI and BT.
It is estimated that the establishment of the new agency would be a viable investment. Even at
the benefit rate of 0.5%, with the expected cost of disease outbreaks over the 30 years totalling
£4118 million (1925, 8440), and after the set-up and annual running costs are accounted for
(£14.3 million and £2.7 million, respectively), the new agency would benefit £21 million (Figure
4). Likewise, if the new agency could achieve a reduction of 2% in the cost of animal disease
outbreaks over 30 years (Scenario B), there would be a benefit of £80 million. However, the
potential benefits calculated based on the estimated costs of animal disease outbreaks were
highly sensitive to the potential for an outbreak of unknown major disease (UMD). According to
Defra’s historical data (Defra 2009b), an outbreak of UMD has been in the past a highly unlikely
event (1 in 100 years). Although if realised a UMD is estimated to cause very high costs that are
similar in scale to the Bovine Spongiform Encephalopathy (BSE) outbreak in the UK during the
1980s/early 1990s, i.e., £5 billion.
Decision-making is complex and dynamic, particularly with regard to animal diseases.
Qualitative factors such as technological (e.g., new vaccines), political (e.g., changing regulation
on vaccination), and social considerations (e.g., cultures that may obstruct investment options)
should also be considered (Khan 2008; Nowak 2005). In addition, the most economically
(quantitatively) viable decision may not necessarily be favoured by Governments. Our future
work will be focusing on stochastic processes including non-homogenous Poisson processes,
Cox processes and mixed processes to model the occurrences of disease outbreaks. When costs
associated with the occurrences of disease outbreaks are considered, marked Poisson processes
models are suggested.
CONCLUSION
This paper explored the applicability of a stochastic model to enhance the RP approach to
animal disease risk assessment. The static nature of the RP approach limits its applicability for
projecting the variability of the number of outbreaks over the lifespan of the proposed new
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agency for animal health in England. However, taking a stochastic approach this variability can
be incorporated. The results from the stochastic model show that the average total cost of the
new agency (including outbreak, set-up and running costs) is £4118 million with £1925 million
and £8440 million as the 90% certainty interval. The large variability associated with the cost is
attributable to the possibility of an UMD outbreak, although BT, FMD, and AI were also
influential on the potential costs for the new agency. The results from the stochastic model also
show that the new agency is likely to be a viable investment even with only a 0.5% reduction in
disease costs, which could potentially save £21 million. The stochastic approach offers Defra an
enhanced approach to the RP method for dealing with the uncertainties in any continuing
deliberations regarding the proposed new agency.
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Table 1. Potential occurrence and costs of minor and major outbreaks (Defra 2009b). The yi and
ci,major of “unknown major disease” were determined by Defra (2009b) based on their historical data
of outbreaks that are, for example, similar in scale to the BSE outbreak in the UK during the
1980s/early 1990s, and have been in the past highly unlikely event (1% risk in any year) but if it
should arise it would cause very high costs (e.g., £5 billion – similar in scale to BSE). The very high
cost of such an event leads to the high “expected annual cost”.
Disease
Disease
indicator
(i)
Main
species
affected
Chance of
outbreak
once every
“how many
years” (yi)
Probability that
outbreak is
Incident cost £M if
outbreak is
Minor
Pi,Minor
Major
Pi, Major
Minor
ci, Minor
Major
ci, Major
Avian Influenza
(AI)
1 Poultry 0.5 0.9 0.1 5 60
Bluetongue
(BT)
2 Cattle, goats,
sheep
2 0.9 0.1 70 200
Newcastle Disease
(ND)
3 Poultry 3 0.95 0.05 5 60
Classical Swine
Fever (CSF)
4 Pigs 8 0.7 0.3 10 90
Foot and Mouth
Disease (FMD)
5 Cattle, goats,
sheep
15 0.9 0.1 100 500
African Swine Fever
(ASF)
6 Pigs 12 0.7 0.3 15 120
Swine Vesicular
Disease (SVD)
7 Pigs 20 0.95 0.05 5 50
Unknown major
disease (UMD)
8 Unknown 100 0 1 - 5000
Other known
notifiable not listed
above (OKN)
9 Various 8 0.7 0.3 5 20
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Figure 1. Box-plot for the estimated number of minor outbreaks over a 30-year period (Oi,Minor).
Figure 2. Box-plot for the estimated number of major outbreaks (Oi,Major).
A
I
B
T
N
D
C
SF
FM
D
A
SF
SV
D
U
M
D
O
K
N
Disease
0
10
20
30
40
50
60
70
N
um
be
r
of
m
in
or
ou
tb
re
ak
s
95%
75%
Mean
25%
5%
15
Figure 3. Estimated costs mean, 5th percentile and 95th percentile of minor and major outbreaks
in a 30-year period.
Figure 4. Total costs of animal disease outbreak reduced accordingly for each scenario over 30
years. A = 0.5% benefit, B = 2% benefit, C = 10% benefit, and D = 0.5%, 2%, and 10% benefit
for years 1–10, 11–20, and 21–30, respectively. The dashed line denotes the estimated average
total cost of animal disease outbreak without any financial benefits from setting up the new
agency (i.e., £4118 million).
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Figure 5. A scenario analysis for the probability of an outbreak of disease i being minor (Pi,Minor)
showing the effect of an improved outbreak response initiative on the mean expected total cost of
disease outbreaks without financial benefits from setting up the new agency.
Figure 6. Sensitivity analysis to assess the relative importance of the variables on the total costs of
animal disease outbreaks over a 30-year period.
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